Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.52B |
| 2 |
Apple
AAPL
|
+$1B |
| 3 |
MetLife
MET
|
+$797M |
| 4 |
Chevron
CVX
|
+$491M |
| 5 |
Applied Materials
AMAT
|
+$471M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$937M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$706M |
| 3 |
Gilead Sciences
GILD
|
+$618M |
| 4 |
IBM
IBM
|
+$567M |
| 5 |
AstraZeneca
AZN
|
+$484M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.15% |
| 2 | Financials | 14.08% |
| 3 | Technology | 12.63% |
| 4 | Energy | 11.41% |
| 5 | Industrials | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRFS
2101
Grifois
GRFS
$5.4B
| – | – |
-113,600
| Closed | -$2.35M |
|
2102
Hanmi Financial
HAFC
$946M
| – | – |
-48,207
| Closed | -$1.12M |
|
2103
Hain Celestial
HAIN
$53.7M
| – | – |
-6,054
| Closed | -$277K |
|
2104
Halozyme
HALO
$12.2B
| – | – |
-85,000
| Closed | -$1.08M |
|
2105
Highwoods Properties
HIW
$3.47B
| – | – |
-49,500
| Closed | -$1.9M |
|
2106
HSBC
HSBC
$356B
| – | – |
-6,468,894
| Closed | -$283M |
|
2107
Hilltop Holdings
HTH
$2.24B
| – | – |
-22,589
| Closed | -$537K |
|
|
IIF
2108
Morgan Stanley India Investment Fund
IIF
$220M
| – | – |
-130,438
| Closed | -$2.55M |
|
2109
Interparfums
IPAR
$3.94B
| – | – |
-14,200
| Closed | -$514K |
|
|
IRBT
2110
DELISTED
iRobot
IRBT
| – | – |
-123,610
| Closed | -$5.07M |
|
2111
ITT
ITT
$19.1B
| – | – |
-11,234
| Closed | -$481K |
|
2112
KLA
KLAC
$259B
| – | – |
-72,340
| Closed | -$500K |
|
2113
Leidos
LDOS
$17.3B
| – | – |
-24,180
| Closed | -$855K |
|
2114
Lindsay Corp
LNN
$1.18B
| – | – |
-73,137
| Closed | -$6.45M |
|
2115
lululemon athletica
LULU
$14.6B
| – | – |
-8,665,200
| Closed | -$456M |
|
2116
Live Nation Entertainment
LYV
$42.1B
| – | – |
-18,909
| Closed | -$411K |
|
2117
Marriott International
MAR
$92.3B
| – | – |
-22,401
| Closed | -$1.25M |
|
2118
Mercado Libre
MELI
$92.3B
| – | – |
-302,405
| Closed | -$28.8M |
|
|
MODV
2119
DELISTED
ModivCare
MODV
| – | – |
-29,386
| Closed | -$831K |
|
2120
Morningstar
MORN
$7.53B
| – | – |
-6,095
| Closed | -$482K |
|
2121
Murphy USA
MUSA
$9.61B
| – | – |
-4,973
| Closed | -$202K |
|
2122
NACCO Industries
NC
$320M
| – | – |
-46,409
| Closed | -$575K |
|
2123
Nice
NICE
$5.97B
| – | – |
-31,950
| Closed | -$1.43M |
|
2124
National Presto Industries
NPK
$989M
| – | – |
-21,517
| Closed | -$1.68M |
|
2125
Patrick Industries
PATK
$2.85B
| – | – |
-992,706
| Closed | -$13M |
|
Similar funds
Wellington Management Group's Q2 2014 Portfolio in Review
As of Q2 2014, Wellington Management Group held 2,343 positions worth $372B, up 3.2% from $360B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Wellington Management Group's Q2 2014 filing shows 204 new, 793 increased, 921 reduced and 197 closed positions. Its largest new stake was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M. The largest sale was Teva Pharmaceuticals, an estimated $937M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
- Wellington Management Group's largest Q2 2014 buy was IMS HEALTH HLDGS INC COM STK (DE): 18,373,009 shares worth $472M.
- Wellington Management Group added most to Bristol-Myers Squibb in Q2 2014, an estimated $1.52B increase.
- Wellington Management Group's biggest Q2 2014 reduction was Teva Pharmaceuticals, cutting an estimated $937M.
- Wellington Management Group fully exited lululemon athletica in Q2 2014, selling an estimated $456M.
- Wellington Management Group's ten largest holdings make up 15% of its $372B portfolio in Q2 2014.
- Wellington Management Group opened 204 new positions and closed 197 in Q2 2014.
- Wellington Management Group's portfolio value rose 3.2% quarter-over-quarter to $372B.
Based on Wellington Management Group's 13F filing for Q2 2014, filed 14 Aug 2014.